Lifemd, INC 10-Q quarterly reports

LifeMD, Inc. filed its Form 10-Q for the quarter ended June 30, 2026, reporting a net loss of $7.1 million and a 4% decrease in revenue compared to the prior year, driven by lower product sales.

LifeMD reports Q1 2026 results with $50.2 million in telehealth revenue and highlights ongoing efforts to remediate material weaknesses in internal controls.

LifeMD, Inc. reported a significant reduction in net losses for Q3 and the first nine months of 2025, driven by strong telehealth revenue growth, while announcing the strategic sale of its WorkSimpli subsidiary.

LifeMD, Inc. reported a significant financial turnaround in Q2 2025, achieving positive net income and robust revenue growth driven by its telehealth segment.

LifeMD's Q1 2025 results show a significant revenue increase driven by telehealth growth, with the company reporting net income and improved operational efficiencies.

LifeMD, Inc. has extended its office lease and reported a 38% increase in revenue for the third quarter of 2024, driven by telehealth services.

LifeMD, Inc. saw a significant 41% increase in revenue in the second quarter of 2024, driven by a 67% surge in telehealth revenue, while also addressing internal control weaknesses.

LifeMD, Inc. saw a 33% increase in revenue in the first quarter of 2024, driven by a 53% surge in telehealth revenue and a 3% increase in WorkSimpli revenue.